Facebook
Twitter
LinkedIn
ForwardJefferson Kidney and Pancreas Transplant Symposium
Overview
This virtual symposium offers an in-depth review of the most clinically-encountered topics in transplantation and to discuss barriers to patients progressing through transplant evaluation to the waiting list. Related topics include:
- Jefferson’s Approach for Promoting Live Kidney Donor Transplantation
- COVID-19 and Transplantation
- Psychosocial and Financial Aspects in Transplant
- Vaccination and Current guidelines: Infectious Disease Perspectives
- Co-Management of Transplant Recipients with Hospital Medicine
Successful Completion
Pharmacists: To successfully complete this activity, the required evaluation must be completed no later than Sunday, May 29, 2022. This is to allow time for upload into CPE Monitor. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.
Physicians/Nurses/Other Health Professionals: To successfully complete this activity, the required evaluation must be completed no later than Monday, June 13, 2022. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.
Target Audience
This course is designed for physicians, physician assistants, nurse practitioners, nurse coordinators, nurses, pharmacists, and social workers.
Learning Objectives
Following completion of this activity, learners will be able to:
- Employ strategies to promote live kidney donation.
- Discuss updates in kidney transplant allocation policy.
- Describe the process of kidney transplant waitlist candidacy and evaluation process.
- Describe multidisciplinary models of post-transplant management.
- Use vaccination recommendations for kidney-pancreas candidates.
- Explain various drug-drug interactions and strategies to improve medication adherence.
- Describe the recent advances, new technologies, and latest developments in the field of renal and pancreas transplantation.
COMMERCIAL/IN-KIND SUPPORT
Any sponsorship received for this educational activity will be published and announced prior to the start of the activity.
AGENDA
Agenda subject to change.
This CE activity is a live virtual meeting. Zoom login information will be provided to registrants prior to the start of the activity.
Conflict of Interest
Thomas Jefferson University endorses the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards. All planners, faculty, authors, presenters, and content reviewers are required to disclose any financial relationships with ACCME defined commercial interest entities within the past 24 months. Any conflict of interests have been mitigated prior to the educational activity.
Such disclosures will be available prior to the start of the activity. Jefferson Conflict of Interest resolution process may result in changes to the program agenda.
Planning Committee
The following planning committee members have no financial relationships to disclose.
Pooja Singh, MD, MBA - Course Director
Anju Yadav, MD, FASN - Course Director
Maria P. Martinez-Cantarin, MD
Maitreyee Gupta, MD
Lauren Palo, MHA, BSN, RN
Sarah Yaeger, PharmD
The following planning committee member has financial relationships to disclose.
Adam M. Frank, MD-Course Director
Royalties or Patent Beneficiary: Cisco Systems, Inc., Intuit Inc, Otis Worldwide Corp, Raytheon Techs Corp
Presenters
The following presenters have no financial relationships to disclose.
Lily L. Ackermann, MD
Katherine Belden, MD
Keira L. Chism, MD
Brenda E. Davis
Jaime Glorioso, MD
Richard Hasz, Jr., MFS, CPTC
Jerry McCauley, MD, MPH
Lauren Palo, MHA, BSN, RN
Ashesh P. Shah, MD
Pooja Singh, MD, MBA
Joanne Weill-Greenberg, MSS, LSW
Linda Wright, DrNP, RN, CNN, CCTC
Anju Yadav, MD, FASN
Sarah Yeager, PharmD
The following presenters have financial relationships to disclose.
Adam M. Frank, MD
Royalties or Patent Beneficiary: Cisco Systems, Inc., Intuit Inc, Otis Worldwide Corp, Raytheon Techs Corp
Rakesh Gulati, MD, MRCP
Consultant: AstraZeneca and Janssen
Off‐label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).
Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
Accreditation
In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physicians: This educational activity is designated for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: This activity awards 6.25 nursing contact hours.
Pharmacists: This knowledge-based continuing education activity is designated for 6.25 contact hours of continuing education credit. UAN JA4008236-0000-22-005-L04-P
Credits will be uploaded to CPE Monitor within 60 days following the completion of this activity.
This statement contains information provided to NABP from the Accreditation Council for Pharmacy Education (ACPE) via CPE Monitor®. ACPE policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor®.
Other Healthcare Professionals: This educational activity is designated for 6.5 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Other Credit Types
PA Patient Safety and Risk credit
This educational activity offers 1.0 credits. The following sessions qualifies: Co-Management of Transplant Recipient with Referring Nephrologists and Post Transplantation: Medication Adherence and Understanding Drug Interactions
Nursing Pharmacology credit
This educational activity offers 1.0 nursing pharmacology credit. The following session qualifies: Immunization in Solid Organ Transplant Recipient and Post Transplantation: Medication Adherence and Understanding Drug Interactions
Available Credit
- 6.25 ACPE
- 6.50 AMA PRA Category 1 Credit™
- 6.50 Attendance
- 6.25 CNE
- 1.00 CNE Pharmacotherapy
- 1.00 Patient Safety
Price
Registration Fees
| Physician | $50 |
| Nurse/Pharmacist/Other Health Professional | $40 |
| Medical Student/Resident/Fellow | Complimentary |
Registration Information
To register online, you must have a CPD @ JeffLearn account.
- Login or create an account. - Note: This website will not work on Internet Explorer 8.
- You must be logged in to see the "Add to Cart" function. Final price will be reflected on check out.
- Check out and pay with American Express, Visa or Mastercard.
Refunds
No refunds will be given after Friday, April 15, 2022. See full refund policy.
Requests for refunds must be submitted in writing and received by OCPD before Friday, April 15, 2022 . Registrants who fail to attend the conference are responsible for the entire registration fee. All refunds will be processed after the conference concludes.
Should any emergency arise, of any nature, prior to the opening conference date that would prevent its schedule opening (destruction or damage to the facility by fire, flood, storms, acts of God, etc., or declaration of any emergency by the state of Pennsylvania or the United States Government), Jefferson reserves the right to cancel or postpone the conference. In the event of cancellation or postponement, Jefferson will refund registration fees, but is not responsible for related costs or expenses to registrants, including cancellation fees assessed by hotels, airlines or travel agencies.
RECORDING AND PHOTOGRAPHY STRICTLY PROHIBITED
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be removed from the online activity or asked to leave from the live activity. No credits or refund will be issued.
JEFFERSON RELEASE POLICY
Jefferson may record/livestream/photograph this activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive any right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt and distribute at any time in any manner or medium.
You understand that it is your right to withhold consent to this Jefferson policy or to withdraw your previous consent at any time. You further understand that, without your consent, it is not possible to process your course registration request.
JEFFERSON HIPAA POLICY
You understand that, as an attendee of this conference hosted by Thomas Jefferson University, Jefferson University Physicians and Thomas Jefferson University Hospitals, Inc. (collectively “Jefferson”), you may gain access to certain proprietary information (“Confidential Information”), including Protected Health Information (“PHI”).
You agree to maintain the confidentiality of all Confidential Information, including PHI, obtained from any source. You agree that you will take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the activity.
In furtherance of the above, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information by the undersigned may result in possible legal action against you by Jefferson whose confidentiality is breached.